82 related articles for article (PubMed ID: 1721338)
1. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
Shaw BW; Markin R; Stratta R; Langnas A; Donovan J; Sorrell M
Transplant Proc; 1991 Dec; 23(6):2994-5. PubMed ID: 1721338
[No Abstract] [Full Text] [Related]
2. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
[No Abstract] [Full Text] [Related]
3. Rejection: FK 506 for rescue or maintenance.
Klintmalm GB; Gibbs JF; McMillan R; Backman L; Levy M; Goldstein RM; Husberg BS; Holman MJ; Gonwa TA
Transplant Proc; 1993 Apr; 25(2):1914-5. PubMed ID: 7682356
[No Abstract] [Full Text] [Related]
4. FK 506 rescue therapy in liver transplantation: outcome and complications.
McDiarmid SV; Klintmalm G; Busuttil RW
Transplant Proc; 1991 Dec; 23(6):2996-9. PubMed ID: 1721339
[No Abstract] [Full Text] [Related]
5. FK 506 treatment of intractable rejection after liver transplantation.
Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R
Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
[No Abstract] [Full Text] [Related]
6. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
[No Abstract] [Full Text] [Related]
7. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
[No Abstract] [Full Text] [Related]
8. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
[No Abstract] [Full Text] [Related]
9. Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
Reggiani P; Orsenigo R; Gatti S; Albani AP; Ferla G; Doglia M; Fassati LR; Galmarini D
Transplant Proc; 1994 Dec; 26(6):3597-8. PubMed ID: 7527982
[No Abstract] [Full Text] [Related]
10. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
[TBL] [Abstract][Full Text] [Related]
11. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
[No Abstract] [Full Text] [Related]
13. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
[No Abstract] [Full Text] [Related]
14. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
[No Abstract] [Full Text] [Related]
15. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
16. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
17. Compassionate use of FK 506 in liver transplantation.
Murio JE; Balsells J; Lázaro JL; Charco R; Margarit C
Transplant Proc; 1995 Aug; 27(4):2336. PubMed ID: 7544501
[No Abstract] [Full Text] [Related]
18. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
[No Abstract] [Full Text] [Related]
19. Outcome analysis of FK 506 therapy for acute and chronic rejection.
Gibbs JF; Husberg BS; Klintmalm GB; Backman L; Levy M; McMillan R; Goldstein RM; Holman MJ; Gonwa TA; Morris C
Transplant Proc; 1993 Feb; 25(1 Pt 1):622-3. PubMed ID: 7679823
[No Abstract] [Full Text] [Related]
20. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
